| Original language | English (US) |
|---|---|
| Pages (from-to) | 1272-1275 |
| Number of pages | 4 |
| Journal | JACC: Cardiovascular Interventions |
| Volume | 13 |
| Issue number | 10 |
| DOIs | |
| State | Published - May 25 2020 |
| Externally published | Yes |
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
In: JACC: Cardiovascular Interventions, Vol. 13, No. 10, 25.05.2020, p. 1272-1275.
Research output: Contribution to journal › Letter › peer-review
}
TY - JOUR
T1 - Diagnostic Accuracy of Nonhyperemic Pressure Ratios Using a Pressure Sensing Microcatheter
T2 - The ACIST-FFR Study
AU - ACIST-FFR Study Investigators
AU - Arashi, Hiroyuki
AU - Kobayashi, Yuhei
AU - Price, Matthew J.
AU - Nishi, Takeshi
AU - Chambers, Jeffrey W.
AU - Seto, Arnold H.
AU - Sarembock, Ian J.
AU - Raveendran, Ganesh
AU - Jeremias, Allen
AU - Fearon, William F.
N1 - Funding Information: Please note: The original work was supported by ACIST Medical Systems. Dr. Kobayashi has been a consultant for ACIST Medical Systems. Dr. Price has been a consultant for AstraZeneca, ACIST Medical, Boston Scientific, Medtronic, St. Jude Medical, and The Medicines Company; and receives speaker fees from AstraZeneca, Abbott Vascular, Medtronic, St. Jude Medical, Terumo, Chiesi USA, and The Medicines Company. Dr. Seto has received research support from ACIST Medical Systems; and has received speaking fees from ACIST Medical Systems and Volcano/Philips. Dr. Sarembock has been a consultant for Boston Scientific. Dr. Raveendran has been a consultant for Zurich Medical. Dr. Jeremias has been a consultant for Abbott Vascular, Philips/Volcano, ACIST Medical Systems, and Boston Scientific; and has served on the Speakers Bureau of Medtronic. Dr. Fearon has received research support from Abbott Vascular and Medtronic; has been a consultant for CathWorks and HeartFlow; and holds minor stock options with HeartFlow. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose. Funding Information: Please note: The original work was supported by ACIST Medical Systems. Dr. Kobayashi has been a consultant for ACIST Medical Systems. Dr. Price has been a consultant for AstraZeneca, ACIST Medical, Boston Scientific, Medtronic, St. Jude Medical, and The Medicines Company; and receives speaker fees from AstraZeneca, Abbott Vascular, Medtronic, St. Jude Medical, Terumo, Chiesi USA, and The Medicines Company. Dr. Seto has received research support from ACIST Medical Systems; and has received speaking fees from ACIST Medical Systems and Volcano/Philips. Dr. Sarembock has been a consultant for Boston Scientific. Dr. Raveendran has been a consultant for Zurich Medical. Dr. Jeremias has been a consultant for Abbott Vascular, Philips/Volcano, ACIST Medical Systems, and Boston Scientific; and has served on the Speakers Bureau of Medtronic. Dr. Fearon has received research support from Abbott Vascular and Medtronic; has been a consultant for CathWorks and HeartFlow; and holds minor stock options with HeartFlow. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
PY - 2020/5/25
Y1 - 2020/5/25
UR - http://www.scopus.com/inward/record.url?scp=85084372440&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85084372440&partnerID=8YFLogxK
U2 - 10.1016/j.jcin.2020.02.031
DO - 10.1016/j.jcin.2020.02.031
M3 - Letter
C2 - 32439000
AN - SCOPUS:85084372440
SN - 1936-8798
VL - 13
SP - 1272
EP - 1275
JO - JACC: Cardiovascular Interventions
JF - JACC: Cardiovascular Interventions
IS - 10
ER -